SIG Brokerage’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
SIG Brokerage's NVS Position: Q3 2026 in Review
SIG Brokerage increased its Novartis (NVS) stake by 915% in Q3 2026, buying an estimated $2.05M and bringing the position to 14,986 shares worth $2.14M. The position accounts for 0.03% of the portfolio, ranked #363.
SIG Brokerage first reported a position in NVS in Q1 2025 and has held it in 3 quarters since. 1,547 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- SIG Brokerage held 14,986 shares of Novartis worth $2.14M as of Q3 2026.
- SIG Brokerage bought 13,510 Novartis shares in Q3 2026, an estimated $2.05M.
- Novartis made up 0.03% of SIG Brokerage's portfolio in Q3 2026, its #363 holding.
- SIG Brokerage first reported a position in Novartis in Q1 2025 and has held it in 3 quarters since.
- 1,547 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on SIG Brokerage's 13F filing for Q3 2026, filed 16 Nov 2026.